Avinger, Inc (AVGR)

Trade AVGR now with
8/21/2019 9:11:18 PM Avinger Prices $4.5 Mln Underwritten Public Offering Of Common Stock
4/10/2019 8:15:19 AM Avinger Receives FDA Clearance Of Pantheris SV Device
3/6/2019 4:14:00 PM Avinger Q4 Loss/share $0.31 Vs. Loss $12.58 Year Ago
12/19/2018 6:02:20 AM Avinger Announces Release Of Preliminary Analysis Of Results From Its SCAN Clinical Study
8/30/2018 8:32:50 AM Avinger Submits New 510(k) Application To FDA For Pantheris SV Lumivascular Atherectomy System
8/23/2018 8:35:00 AM Avinger Completes Enrollment In SCAN Clinical Study
7/12/2018 8:34:56 AM Avinger Announces Pricing Of $3.55 Mln Registered Direct Offering
7/10/2018 8:32:13 AM Avinger Appoints Jaafer Golzar As Chief Medical Officer
6/14/2018 8:31:33 AM Avinger Says First Patients Enrolled In Post-Market Study Comparing Pantheris OCT Imaging To Intravascular Ultrasound
5/23/2018 8:33:50 AM Avinger Gets 510(k) Clearance From FDA For Next Generation Pantheris Lumivascular Atherectomy System
5/14/2018 4:34:33 PM Avinger Q1 Loss/share $5.37 Vs. Loss $25.74 Year Ago
3/29/2018 9:07:42 AM Avinger Reports First-in-Patient Use Of Extended Nosecone Version Of Next Generation Pantheris
3/19/2018 4:02:47 PM Avinger Q4 Loss/share $12.58 Vs. Loss $23.35 Year Ago